This Article Free upon publication Full Text Full Text (PDF) Correction Correction (v117,pe161) All Versions of this Article: 117/2/261    most recent CIRCULATIONAHA.107.188208v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by King, S. B. Articles by Yancy, C. W. Search for Related Content PubMed PubMed Citation Articles by King, S. B., III Articles by Yancy, C. W. Pubmed/NCBI databases Medline Plus Health Information Angioplasty Heart Attack Related Collections AHA Statements and Guidelines

(Circulation. 2008;117:261-295.)
© 2008 American Heart Association, Inc.

PCI Focused Update

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee

Spencer B. King, III, MD, MACC, FAHA, FSCAI, Co-Chair^*,; Sidney C. Smith, Jr, MD, FACC, FAHA, Co-Chair^*,; John W. Hirshfeld, Jr, MD, FACC, FAHA, FSCAI; Alice K. Jacobs, MD, FACC, FAHA, FSCAI; Douglass A. Morrison, MD, PhD, FACC, FSCAI; David O. Williams, MD, FACC, FAHA, FSCAI; 2005 WRITING COMMITTEE MEMBERS; Sidney C. Smith, Jr, MD, FACC, FAHA, Chair; Ted E. Feldman, MD, FACC, FSCAI; John W. Hirshfeld, Jr, MD, FACC, FAHA, FSCAI; Alice K. Jacobs, MD, FACC, FAHA, FSCAI; Morton J. Kern, MD, FACC, FAHA, FSCAI; Spencer B. King, III, MD, MACC, FSCAI; Douglass A. Morrison, MD, PhD, FACC, FSCAI; William W. O’Neill, MD, FACC, FSCAI; Hartzell V. Schaff, MD, FACC, FAHA; Patrick L. Whitlow, MD, FACC, FAHA; David O. Williams, MD, FACC, FAHA, FSCAI; TASK FORCE MEMBERS: Sidney C. Smith, Jr, MD, FACC, FAHA, Chair; Alice K. Jacobs, MD, FACC, FAHA, Vice-Chair; Cynthia D. Adams, MSN, PhD, FAHA^||; Jeffrey L. Anderson, MD, FACC, FAHA^||; Christopher E. Buller, MD, FACC; Mark A. Creager, MD, FACC, FAHA; Steven M. Ettinger, MD, FACC; Jonathan L. Halperin, MD, FACC, FAHA^||; Sharon A. Hunt, MD, FACC, FAHA^||; Harlan M. Krumholz, MD, FACC, FAHA; Frederick G. Kushner, MD, FACC, FAHA; Bruce W. Lytle, MD, FACC, FAHA; Rick Nishimura, MD, FACC, FAHA; Richard L. Page, MD, FACC, FAHA; Barbara Riegel, DNSc, RN, FAHA^||; Lynn G. Tarkington, RN; Clyde W. Yancy, MD, FACC

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 

Preamble...262

1. Introduction...264

   1.1. Evidence Review...264

   1.2. Organization of Committee and Relationships With Industry...264

   1.3. Review and Approval...264

2. Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction...264

   2.1. Electrocardiogram...268

      2.1.1. Comparison of Early Invasive and Initial Conservative Strategies for UA/NSTEMI...269

      2.1.2. Selection for Coronary Angiography...271

      2.1.3. Chronic Kidney Disease...272

3. Facilitated PCI...273

4. Rescue PCI...275

5. PCI After Fibrinolysis or for Patients Not Undergoing Primary Reperfusion...277

6. Ancillary Therapy for Patients Undergoing PCI for STEMI...278

7. Antiplatelet Therapy...278

8. Bare-Metal and Drug-Eluting Stents...281

   8.1. Selection of a Bare-Metal or Drug-Eluting Stent...281

9. Secondary Prevention...283

References...288

Appendix 1...293

Appendix 2...293

	Preamble

 
A primary challenge in the development of clinical practice guidelines is keeping pace with the stream of new data upon which recommendations are based. In an effort to respond more quickly to new evidence, the American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines has created a new "focused update" process to revise the existing guideline recommendations that are affected by evolving data or opinion. Before the initiation of this focused approach, periodic updates and revisions of existing guidelines required up to 3 years to complete. Now, however, new evidence will be reviewed in an ongoing fashion to more efficiently respond to important science and treatment trends that could have a major impact on patient outcomes and quality of care. Evidence will be reviewed at least twice a year, and updates will be initiated on an as needed basis as quickly as possible while maintaining the rigorous methodology that . . . [Full Text of this Article]

Related Internet Resources:

ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article

This article has been cited by other articles:

				E. J. Last and A. H. Sheehan Review of recent evidence: Potential interaction between clopidogrel and proton pump inhibitors Am. J. Health Syst. Pharm., December 1, 2009; 66(23): 2117 - 2122. [Abstract] [Full Text] [PDF]

				A. Cassar, D. R. Holmes Jr, C. S. Rihal, and B. J. Gersh Chronic Coronary Artery Disease: Diagnosis and Management Mayo Clin. Proc., December 1, 2009; 84(12): 1130 - 1146. [Abstract] [Full Text] [PDF]

				S. Schulz, T. Schuster, J. Mehilli, R. A. Byrne, J. Ellert, S. Massberg, J. Goedel, O. Bruskina, K. Ulm, A. Schomig, et al. Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period Eur. Heart J., November 2, 2009; 30(22): 2714 - 2721. [Abstract] [Full Text] [PDF]

				A. Kumar and C. P. Cannon Acute Coronary Syndromes: Diagnosis and Management, Part II Mayo Clin. Proc., November 1, 2009; 84(11): 1021 - 1036. [Abstract] [Full Text] [PDF]

				S. Silber, A. Colombo, A. P. Banning, K. Hauptmann, J. Drzewiecki, E. Grube, D. Dudek, and D. S. Baim Final 5-Year Results of the TAXUS II Trial: A Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for De Novo Coronary Artery Lesions Circulation, October 13, 2009; 120(15): 1498 - 1504. [Abstract] [Full Text] [PDF]

				A. Kumar and C. P. Cannon Acute Coronary Syndromes: Diagnosis and Management, Part I Mayo Clin. Proc., October 1, 2009; 84(10): 917 - 938. [Abstract] [Full Text] [PDF]

				A Sambola, I Ferreira-Gonzalez, J Angel, F Alfonso, J Maristany, O Rodriguez, H Bueno, J R Lopez-Minguez, J Zueco, F Fernandez-Aviles, et al. Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study Heart, September 15, 2009; 95(18): 1483 - 1488. [Abstract] [Full Text] [PDF]

				A. R. Shuldiner, J. R. O'Connell, K. P. Bliden, A. Gandhi, K. Ryan, R. B. Horenstein, C. M. Damcott, R. Pakyz, U. S. Tantry, Q. Gibson, et al. Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy JAMA, August 26, 2009; 302(8): 849 - 857. [Abstract] [Full Text] [PDF]

				J. M. Lasala, D. A. Cox, D. Dobies, K. Baran, W. B. Bachinsky, E. W. Rogers, J. A. Breall, D. H. Lewis, A. Song, R. M. Starzyk, et al. Drug-Eluting Stent Thrombosis in Routine Clinical Practice: Two-Year Outcomes and Predictors From the TAXUS ARRIVE Registries Circ Cardiovasc Interv, August 1, 2009; 2(4): 285 - 293. [Abstract] [Full Text] [PDF]

				G. S. Aldea, N. A. Mokadam, R. Melford Jr, D. Stewart, C. Maynard, M. Reisman, and R. Goss Changing Volumes, Risk Profiles, and Outcomes of Coronary Artery Bypass Grafting and Percutaneous Coronary Interventions. Ann. Thorac. Surg., June 1, 2009; 87(6): 1828 - 1838. [Abstract] [Full Text] [PDF]

				A. Prasad and D. R Holmes Update on dual antiplatelet therapy for percutaneous coronary intervention Heart, June 1, 2009; 95(11): 861 - 865. [Full Text] [PDF]

				J. L. Mega, S. L. Close, S. D. Wiviott, L. Shen, R. D. Hockett, J. T. Brandt, J. R. Walker, E. M. Antman, W. L. Macias, E. Braunwald, et al. Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel: Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes Circulation, May 19, 2009; 119(19): 2553 - 2560. [Abstract] [Full Text] [PDF]

				A. Sourgounis, J. Lipiecki, T. S. Lo, and M. Hamon Coronary Stents and Chronic Anticoagulation Circulation, March 31, 2009; 119(12): 1682 - 1688. [Full Text] [PDF]

				E. M. Antman and E. D. Peterson Tools for Guiding Clinical Practice From the American Heart Association and the American College of Cardiology: What Are They and How Should Clinicians Use Them? Circulation, March 10, 2009; 119(9): 1180 - 1185. [Full Text] [PDF]

				P. W. Serruys, M.-C. Morice, A. P. Kappetein, A. Colombo, D. R. Holmes, M. J. Mack, E. Stahle, T. E. Feldman, M. van den Brand, E. J. Bass, et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease N. Engl. J. Med., March 5, 2009; 360(10): 961 - 972. [Abstract] [Full Text] [PDF]

				S. Goldfarb, P. A. McCullough, J. McDermott, and S. B. Gay Contrast-Induced Acute Kidney Injury: Specialty-Specific Protocols for Interventional Radiology, Diagnostic Computed Tomography Radiology, and Interventional Cardiology Mayo Clin. Proc., February 1, 2009; 84(2): 170 - 179. [Abstract] [Full Text] [PDF]

				J. L. Mega, S. L. Close, S. D. Wiviott, L. Shen, R. D. Hockett, J. T. Brandt, J. R. Walker, E. M. Antman, W. Macias, E. Braunwald, et al. Cytochrome P-450 Polymorphisms and Response to Clopidogrel N. Engl. J. Med., January 22, 2009; 360(4): 354 - 362. [Abstract] [Full Text] [PDF]

				F.L. Lucas, A.E. Siewers, D.J. Malenka, and D.E. Wennberg Diagnostic-Therapeutic Cascade Revisited: Coronary Angiography, Coronary Artery Bypass Graft Surgery, and Percutaneous Coronary Intervention in the Modern Era Circulation, December 16, 2008; 118(25): 2797 - 2802. [Abstract] [Full Text] [PDF]

				L. Ang and E. Mahmud Monitoring oral antiplatelet therapy: is it justified? Therapeutic Advances in Cardiovascular Disease, December 1, 2008; 2(6): 485 - 496. [Abstract] [PDF]

				M. Zimarino and R. De Caterina Long-term treatment strategies for atherothrombotic disease: do platelets define the course? Eur. Heart J. Suppl., November 1, 2008; 10(suppl_I): I8 - I13. [Abstract] [Full Text] [PDF]

				J. Sullivan and N. Amarshi Dual antiplatelet therapy with clopidogrel and aspirin Am. J. Health Syst. Pharm., June 15, 2008; 65(12): 1134 - 1143. [Abstract] [Full Text] [PDF]

				L. Mosca Aspirin Chemoprevention: One Size Does Not Fit All Circulation, June 3, 2008; 117(22): 2844 - 2846. [Full Text] [PDF]

				A J. Hermosillo and S. A Spinler Aspirin, Clopidogrel, and Warfarin: Is the Combination Appropriate and Effective or Inappropriate and Too Dangerous? Ann. Pharmacother., June 1, 2008; 42(6): 790 - 805. [Abstract] [Full Text] [PDF]

				D. A. Morrow Antithrombotic Therapy to Support Primary PCI N. Engl. J. Med., May 22, 2008; 358(21): 2280 - 2282. [Full Text] [PDF]

				S. H Bhatt and T. H Hauser Very Late Stent Thrombosis After Dual Antiplatelet Therapy Discontinuation in a Patient with a History of Acute Stent Thrombosis Ann. Pharmacother., May 1, 2008; 42(5): 708 - 712. [Abstract] [Full Text] [PDF]